Movicol and Gastrointestinal inflammation - a phase IV clinical study of FDA data
Summary:
Gastrointestinal inflammation is reported as a side effect among people who take Movicol (polyethylene glycol 3350), especially for people who are male, 60+ old, also take Neulasta, and have Colorectal cancer metastatic.
The phase IV clinical study analyzes which people have Gastrointestinal inflammation when taking Movicol. It is created by eHealthMe based on reports of 14,199 people who have side effects when taking Movicol from the FDA, and is updated regularly.
What is Movicol?
Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.
What is Gastrointestinal inflammation?
Gastrointestinal inflammation (inflammation of stomach and intestine) is found to be associated with 541 drugs and 548 conditions by eHealthMe. Check the latest studies of Gastrointestinal inflammation.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
14,199 people reported to have side effects when taking Movicol.
Among them, 13 people (0.09%) have Gastrointestinal inflammation.

Among these 13 people:
What is the gender of people who have Gastrointestinal inflammation when taking Movicol? *
- female: 30.77 %
- male: 69.23 %
What is the age of people who have Gastrointestinal inflammation when taking Movicol? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
What are other drugs people take besides Movicol? *
- Imodium: 5 people, 38.46%
- Lasix: 5 people, 38.46%
- Xanax: 5 people, 38.46%
- Neulasta: 5 people, 38.46%
- Aloxi: 4 people, 30.77%
- Solu-Medrol: 4 people, 30.77%
- Mesalamine: 3 people, 23.08%
- Mycophenolate Mofetil: 3 people, 23.08%
- Hydrochlorothiazide: 3 people, 23.08%
- Omeprazole: 3 people, 23.08%
What are other side effects people have besides Gastrointestinal inflammation? *
- Endocarditis (inflammation in heart muscle): 5 people, 38.46%
- Nausea (feeling of having an urge to vomit): 3 people, 23.08%
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 3 people, 23.08%
- Colitis (inflammation of colon): 3 people, 23.08%
- Fever: 2 people, 15.38%
- Diarrhea: 2 people, 15.38%
- Dizziness: 2 people, 15.38%
- Diverticulum Intestinal (a pouch that is attached to the first part of the small intestine): 2 people, 15.38%
- Gastrointestinal Infection (infection of stomach and intestine): 2 people, 15.38%
- Haematochezia (passage of stools containing blood): 2 people, 15.38%
What are the existing conditions these people have? *
- Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 5 people, 38.46%
- Immunodeficiency Disorders: 2 people, 15.38%
- Breast Cancer Metastatic: 2 people, 15.38%
- Rhinorrhea (watery mucus discharge from the nose): 1 person, 7.69%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
- Parkinson's Disease: 1 person, 7.69%
- High Blood Pressure: 1 person, 7.69%
- Diabetes: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Movicol and have Gastrointestinal inflammation?
- Check whether Gastrointestinal inflammation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Movicol:
- Movicol (14,249 reports)
Gastrointestinal inflammation treatments and more:
- Gastrointestinal inflammation (9,479 reports)
How severe was Gastrointestinal inflammation and when was it recovered:
Expand to all the drugs that have ingredients of polyethylene glycol 3350:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Movicol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Gastrointestinal inflammation:
- Gastrointestinal inflammation (541 drugs)
Browse all the conditions that are associated with Gastrointestinal inflammation:
- Gastrointestinal inflammation (548 conditions)
Related publications that referenced our studies
- Schwerd T, Pandey S, Yang HT, Bagola K, Jameson E, Jung J, Lachmann RH, Shah N, Patel SY, Booth C, Runz H, "Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann–Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn9s disease", Gut, 2016 Mar .
- Schwerd T, Pandey S, Yang HT, Bagola K, Jameson E, Jung J, Lachmann RH, Shah N, Patel SY, Booth C, Runz H, "Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann–Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn9s disease", Gut, 2016 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Movicol) and Movicol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Topiramate cause Herpes Simplex Aggravated? - 3 seconds ago
- Could Magnesium Citrate cause Hot Flush? - 3 seconds ago
- Could Valproic Acid cause Stereotypy? - 7 seconds ago
- Drug interactions of Ademetionine and Magnesium - 12 seconds ago
- Could Wellbutrin cause Jaw Disorder? - 14 seconds ago
- Could Exidine cause Facial Paresis? - 15 seconds ago
- Could Losartan Potassium cause Oedema Lower Limb? - 15 seconds ago
- Could Busulfex cause Device Related Infection? - 17 seconds ago
- Could Tramadol cause Biliary Tract Disorder? - 24 seconds ago
- Could Alkeran cause Gynecomastia? - 29 seconds ago